Table 1.
Baseline characteristics
| Patients (n=33) | ||
|---|---|---|
| Age, years | 48·0 (13·0) | |
| Body-mass index, kg/m2 | 28·0 (5·3) | |
| Ethnicity | ||
| White | 29 (88%) | |
| Afro-Caribbean | 1 (3%) | |
| Asian | 1 (3%) | |
| Arabic | 2 (6%) | |
| Comorbidity | ||
| Diabetes | 1 (3%) | |
| Smoking | 3 (9%) | |
| Tumour laterality | ||
| Left | 13 (39%) | |
| Right | 20 (61%) | |
| Tumour subtype | ||
| Invasive ductal carcinoma | 27 (82%) | |
| Invasive lobular carcinoma | 6 (18%) | |
| Tumour stage | ||
| T2 | 11 (33%) | |
| T3 | 17 (52%) | |
| T4b (involved nipple areolar complex) | 5 (15%) | |
| Receptor status | ||
| Oestrogen receptor-positive | 25 (76%) | |
| Progesterone receptor-positive | 22 (67%) | |
| HER2-positive | 8 (24%) | |
| Triple-negative breast cancer | 4 (12%) | |
| Nodal stage | ||
| 0 | 8 (24%) | |
| I | 21 (64%) | |
| II | 3 (9%) | |
| III | 1 (3%) | |
Data are median (IQR) or n (%).